FDA Guidance for Industry Providing Regulatory Submissions to CBER in Electronic Format — Investigational New Drug Applications (INDs)
Title:
FDA Guidance for Industry
Providing Regulatory Submissions to
CBER in Electronic Format —
Investigational New Drug Applications
(INDs)
Origin/Publisher:
Freedom of Information Staff, (HFI 35), Food and Drug Administration, Rm. 12 A - 30, 5600 Fishers Lane, Rockville, MD 20857, USA, http://www.fda.gov/ , http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/General/UCM150028.pdf
Document Type:
Guidance for Industry
Content:
Providing Regulatory Submissions to
CBER in Electronic Format - INDs